Eclipse Bioinnovations
Eclipse Bioinnovations is a leading RNA genomics company founded in 2017 based on technology developed at the University of California, San Diego. Eclipse's mission is to use their pioneering RNA genomics platform technologies to advance RNA medicines and scientific discovery. Eclipse’s founders developed eCLIP, the world’s most efficient and unique CLIP-seq technology for identifying RNA binding protein gene partners and gene maps. Eclipse’s suite of RNA genomics technologies now cover eCLIP-RBP for mapping the RNA binding proteins, miR-eCLIP for the miR-interactome, m6A-eCLIP for RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for simplifying Crispr library prep. Products are offered as services and kit for biopharma companies and academic researchers, and can be customized for clients.
Domain
eclipsebio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$4.9M
Founded
2016
Tech Stack (22 technologies)
Frequently Asked Questions
What technologies does Eclipse Bioinnovations use?+
Eclipse Bioinnovations uses 22 technologies including HubSpot, WordPress, HubSpot WordPress plugin.
What industry is Eclipse Bioinnovations in?+
Eclipse Bioinnovations operates in the Biotechnology industry.
Where is Eclipse Bioinnovations based?+
Eclipse Bioinnovations is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026